Structural Biology in Cancer Research

The main aim of integrating structural biology data into cancer research is to design and discover novel and effective drugs to cure the disease. Structural biology combined with molecular modelling mainly aims at drug designing. Consequently, a number of Structural Biologists are conducting cancer research, to speed-up the process of understanding the mechanism of biomolecules in order to improve the newer cancer therapies.

Major part of research is being carried out in the area of cancer. The main aim is to design and discover novel and effective drugs to cure the disease. Structural biology combined with molecular modelling mainly aims at drug designing. Subsequently, numerous team leaders in Structural biology carry out cancer research to accelerate the exploitation of molecular understanding of biomolecules in the advancement of novel cancer therapies.

  • Cancer Systems Biology
  • Tumorigenesis
  • Cancer Heterogeneity
  • Epidemiology
  • Statistical and Mechanistic Modelling of Signalling Networks

Related Conference of Structural Biology in Cancer Research

May 10-11, 2019

8th Asia Pacific Glycobiology Congress

Tokyo, Japan
July 11-12, 2019

8th Glycobiology World Congress

Zurich, Switzerland
May 10-11, 2019

4th International Conference on Enzymology & Molecular Biology

| Radisson Hotel Narita | Tokyo, Japan
October 07-08, 2019

4th International Conference on Molecular Biology & Nucleic Acids

Chicago, Illinois, USA

Structural Biology in Cancer Research Conference Speakers

Recommended Sessions

Related Journals

Are you interested in